If you are:
Absolute Contraindication: RISK OF IMMUNE SUPPRESSION, POSSIBLY CARCINOGENIC.
An adult over 60:
management or monitoring precaution: Cardiovascular-Increased risk of myocardial toxicity with history of cardiovascular disease.
Giving doxorubicin-hcl-liposome-vial to a child under 12:
Severe Precaution: No safety and efficacy for liposomal formulation. Non-liposomal form risks: delayed cardiotoxicity and heart failure, prepubertal growth failure, secondary AML, or other malignancy